Skip to content

Moyamoya Disease Omics Atlas

Moyamoya Disease Omics Atlas

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061889
Enrollment
Unknown
Registered
2022-07-06
Start date
2022-07-06
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya Disease

Interventions

Moyamoya group:NA

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with moyamoya disease diagnosed by DSA or MRA; 2. Patients or guardians who agreed to join the study; 3. Patients who can complete the relevant examinations involved in this study; 4. Healthy controls who underwent physical examination in the hospital during the same period.

Exclusion criteria

Exclusion criteria: 1. Known history of cardiac, renal, or systemic vascular diseases; 2. Patients with coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Genomics;Transcriptomics;Proteomics;Metabolomics;Lipidomics;Radiomics;Metagenomics;Amplicons;Immunomics;Single-cell sequencing ;

Countries

China

Contacts

Public ContactDong Zhang

Beijing Tiantan Hospital, Capital Medical University

zhangdong0660@aliyun.com+86 13801121292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026